Send feedback

LDLR p.Val775Ala

c.2324T>C · rs780300776 · VCV440691

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0722 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00263%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
hypercholesterolemia, familial, 1

ClinGen expert panel — Familial Hypercholesterolemia VCEP

Uncertain Significance for hypercholesterolemia, familial. Applied ACMG criteria (verbatim):

PM2 BP4

Curation rationale (ClinGen, verbatim)

The NM_000527.5(LDLR):c.2324T>C (p.Val775Ala) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2 and BP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 28 March 2025. The supporting evidence is follows: PM2: PopMax MAF = 0.00002627 (0.0026%) in European (non-Finnish) exomes+genomes (gnomAD v4.1.0). BP4: REVEL=0.244. It is below 0.5, so splicing evaluation is required. A) not on limits B) does not create AG C) there is an AG nearby. MES scores: variant cryptic = 1.45, wt cryptic = 2.52, canonical acceptor = 11.36. Ratio variant cryptic/wt cryptic: 0.57 --- it is below 1.1. Ratio variant cryptic/canonical acceptor: 0.12--- it is below 0.9. Variant is not predicted to alter splicing.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.0722likely benign
REVEL0.244benign-leaning
SaProtLLR -5.90tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -3.7GERP -2.8
Regional constrainto/e 1.00unconstrained · MANE · 42 kb · p 0.91 · regional, not allelic
Overall
CADD0.104PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00263% European (non-Finnish) · 31/1,180,012 alleles
Filtering AF 0.00188% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00164%
Overall 0.00204% 33/1,613,954 alleles · very rare exomes 29/1,461,874 · genomes 4/152,080 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00263% 38,065
Finnishnot grpmax-eligible 0.00156% 64,016
African / African-American 0.00134% 74,896

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
LDLR
Protein
p.Val775Ala
Coding
c.2324T>C
MANE Select
NM_000527
dbSNP
rs780300776
Type
single nucleotide variant
Location
chr19:11128020 (GRCh38)
Gene constraint
LOEUF 1.091 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 75.81 · 36 PDB
Full LDLR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ldlr-p-val775ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown